Affiliation: Humboldt University
- Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infantsCornelia Feiterna-Sperling
Charite, Department of Pediatric Pneumology and Immunology, University Medicine Berlin, Berlin, Germany
J Acquir Immune Defic Syndr 45:43-51. 2007..A prospective observational study to investigate hematologic alterations during the first 3 months of life in HIV-exposed uninfected infants subjected to antiretroviral medication before and after birth...
- Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infantCornelia Feiterna-Sperling
Department of Pediatric Pneumology, Charite, University Medicine Berlin, Berlin, Germany
Pediatr Infect Dis J 27:564-7. 2008..Here, we report the case of a preterm infant with HIV-related life-threatening PAH, which resolved after initiation of highly active antiretroviral therapy...
- A 12-year-old boy with multidrug-resistant human immunodeficiency virus type 1 successfully treated with HAART including ritonavir-boosted tipranavir oral solution and enfuvirtideCornelia Feiterna-Sperling
Charite, Campus Virchow Klinikum, Department of Pediatric Pneumology and Immunology, Augustenburger Platz 1, 13353 Berlin, Germany
Eur J Med Res 14:44-6. 2009....
- Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected childrenCornelia Feiterna-Sperling
Department of Pediatric Pneumology and Immunology, Helmut Ruska Haus, Charite Universitatsmedizin Berlin, Berlin, Germany
Clin Infect Dis 51:e90-4. 2010..Oseltamivir shortened the duration of viral shedding...
- Granulysin-expressing CD4+ T cells as candidate immune marker for tuberculosis during childhood and adolescenceHenrik Mueller
Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany
PLoS ONE 6:e29367. 2011..Granulysin produced by cytolytic T cells directly contributes to immune defense against tuberculosis (TB). We investigated granulysin as a candidate immune marker for childhood and adolescent TB...
- Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescentsJuan C Salazar
Connecticut Children s Medical Center, University of Connecticut School of Medicine, Hartford, Connecticut 06106, USA
AIDS 22:1789-98. 2008..To evaluate the efficacy, safety and tolerability of ritonavir-boosted tipranavir (TPV/r) in HIV-1-infected pediatric patients...
- Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonatesThomas Schmitz
AIDS 20:1082-3. 2006